U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Aug. 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Health Catalyst, Nektar Therapeutics and TIC Solutions, on Friday. **Highlights** - Bowman Consulting Group Ltd: JPMorgan cuts to **underweight** from neutral - Health Catalyst Inc: Canaccord Genuity cuts to **hold** from buy - Nektar Therapeutics: JPMorgan resumes coverage with **neutral** rating - Sterling Infrastructure Inc: D.A. Davidson initiates coverage with **buy** rating - TIC Solutions Inc: JPMorgan raises to **neutral** from underweight Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order. - Abbott: TD Cowen raises target price to **$135** from $115 - Accel Entertainment Inc: Wells Fargo initiates coverage with **equal weight** rating; target price **$14** - Advance Auto Parts Inc: BMO cuts target price to **$50** from $65 - Advance Auto Parts Inc: Citigroup cuts target price to **$45** from $57 - Advance Auto Parts Inc: D.A. Davidson cuts target price to **$48** from $58 - Advance Auto Parts Inc: TD Cowen cuts target price to **$45** from $61 - Advance Auto Parts Inc: Truist Securities cuts target price to **$43** from $62 - Advance Auto Parts Inc: Barclays cuts target price to **$50** from $59 - Advance Auto Parts Inc: Wells Fargo cuts target price to **$50** from $60 - Advanced Micro Devices: BMO initiates coverage with **outperform** rating; target price **$550** - Ameriprise Financial Inc: Raymond James raises target price to **$638** from $582 - Analog Devices Inc: BMO initiates coverage with **outperform** rating; target price **$430** - Applovin Corporation: Piper Sandler cuts target price to **$325** from $385 - Autodesk Inc: Baird raises target price to **$325** from $312 - Bowman Consulting Group Ltd: JPMorgan cuts to **underweight** from neutral; raises target price to **$43** from $40 - Broadcom Inc: BMO initiates coverage with **outperform** rating; target price **$455** - Brown-Forman Corporation: JPMorgan raises target price to **$26** from $23 - California Bancorp: Raymond James initiates coverage with **outperform** rating; target price **$25** - Claritev Corp: Barclays raises target price to **$40** from $28 - Comfort Systems USA Inc: D.A. Davidson initiates coverage with **buy** rating; target price **$2,100** - Coty Inc: Deutsche Bank raises target price to **$3** from $2 - Deere & Co: BofA Global Research raises price objective to **$667.00** from $607.50 - Deere & Co: Citigroup raises target price to **$650** from $610 - Deere & Co: Daiwa Capital Markets raises target price to **$705** from $610 - Deere & Co: JPMorgan raises target price to **$585** from $570 - DoubleVerify Holdings Inc: JPMorgan cuts target price to **$13.60** from $14; cuts to **neutral** from overweight - Doximity: Barclays raises target price to **$27** from $20 - D-Wave Quantum Inc: BMO initiates coverage with **outperform** rating; target price **$35** - Emergent BioSolutions Inc: JPMorgan resumes coverage with **underweight** rating - Everpure Inc: Wedbush raises target price to **$127** from $105 - Everus Construction Group Inc: D.A. Davidson initiates coverage with **buy** rating; target price **$168** - Faeth Therapeutics Inc: Needham initiates coverage with **buy** rating; price target **$56** - Ferguson Enterprises Inc: Morgan Stanley raises target price to **$295** from $290 - Health Catalyst Inc: Canaccord Genuity cuts target price to **$1.8** from $3; cuts to **hold** from buy - Hecla Mining Co: Jefferies initiates coverage with **hold** rating; target price **$22** - Horizon Technology Finance Corporation: KBW cuts target price to **$4.5** from $5 - Imagenebio Inc: H.C. Wainwright initiates coverage with **buy** rating; price target **$28** - Impinj Inc: BMO initiates coverage with **outperform** rating; target price **$220** - Innovage Holding Corp: KeyBanc raises to **overweight** from sector weight - Limbach Holdings Inc: JPMorgan cuts target price to **$50** from $60; cuts to **underweight** from neutral - Macom Technology Solutions Holdings Inc: BMO initiates coverage with **market perform** rating; target price **$335** - Marvell Technology Inc: Oppenheimer raises target price to **$300** from $250 - Marvell Technology Inc: BMO initiates coverage with **outperform** rating; target price **$250** - Marvell Technology Inc: Citigroup raises target price to **$275** from $225 - Matthews International Corp: Truist Securities initiates coverage with **hold** rating; target price **$24** - MBX Biosciences Inc: JPMorgan resumes coverage with **overweight** rating; target price **$88** - Microchip Technology: BMO initiates coverage with **outperform** rating; target price **$95** - Micron Technology Inc: BMO initiates coverage with **outperform** rating; target price **$1,300** - Mobility Global: BofA Global Research initiates coverage with **neutral** rating; price objective **$23.00** - Moderna: JPMorgan raises target price to **$77** from $40 - Myriad Genetics Inc: Jefferies cuts target price to **$2.5** from $4 - Nektar Therapeutics: JPMorgan resumes coverage with **neutral** rating; target price **$65** - Nvidia Corporation: BMO initiates coverage with **outperform** rating; target price **$340** - Nvidia Corporation: HSBC raises target price to **$360** from $325 - O-I Glass Inc: Citigroup raises to **buy** from neutral; target price to **$9** from $8 - Okta Inc: JPMorgan raises target price to **$165** from $120 - Portland General Electric Company: Wells Fargo raises target price to **$58** from $51; raises to **overweight** from equal weight - Revolution Medicines Inc: Bernstein raises target price to **$179** from $151 - Rockwell Automation Inc: D.A. Davidson cuts target price by **$10** to **$490** - Ross Stores Inc: Barclays raises target price to **$298** from $260 - Ross Stores Inc: Bernstein raises target price to **$240** from $230 - Ross Stores Inc: BofA Global Research raises price objective to **$265** from $255 - Ross Stores Inc: Citigroup raises target price to **$290** from $270 - Ross Stores Inc: Deutsche Bank raises target price to **$294** from $283 - Ross Stores Inc: Evercore ISI raises target price to **$290** from $276 - Ross Stores Inc: Jefferies raises target price to **$285** from $265 - Ross Stores Inc: JPMorgan raises target price to **$272** from $262 - Ross Stores Inc: Truist Securities raises target price to **$310** from $290 - Ross Stores Inc: Wells Fargo raises target price to **$248** from $245 - Select Water Solutions Inc: JPMorgan initiates coverage with **overweight** rating; target price **$24** - Semtech Corporation: BMO initiates coverage with **outperform** rating; target price **$155** - SentinelOne Inc: JPMorgan raises target price to **$22** from $18 - Skyworks Solutions Inc: BMO initiates coverage with **market perform** rating; target price **$70** - Sterling Infrastructure Inc: D.A. Davidson initiates coverage with **buy** rating; target price **$700** - Stoke Therapeutics Inc: JPMorgan resumes coverage with **overweight** rating; target price **$40** - Estée Lauder Companies: Barclays raises target price to **$97** from $80 - TIC Solutions Inc: JPMorgan raises target price to **$11** from $9; raises to **neutral** from underweight - Vivmark Residential: Wells Fargo initiates coverage with **overweight** rating; price target **$72** - Walmart Inc: BMO cuts target price to **$126** from $145 - Walmart Inc: BofA Global Research cuts price objective to **$126** from $144 - Walmart Inc: BTIG cuts target price to **$140** from $145 - Walmart Inc: Citigroup cuts target price to **$132** from $147 - Walmart Inc: D.A. Davidson cuts target price to **$132** from $150 - Walmart Inc: Deutsche Bank cuts target price to **$113** from $120 - Walmart Inc: JPMorgan cuts target price to **$125** from $137 - Walmart Inc: Morgan Stanley cuts target price to **$125** from $140 - Walmart Inc: Piper Sandler cuts target price to **$128** from $137 - Walmart Inc: Raymond James cuts target price to **$130** from $135 - Walmart Inc: RBC cuts target price to **$131** from $137 - Walmart Inc: TD Cowen cuts target price to **$125** from $150 - Walmart Inc: Telsey Advisory Group cuts target price to **$130** from $140 - Walmart Inc: Truist Securities cuts target price to **$114** from $140 - Walmart Inc: Wells Fargo cuts target price to **$120** from $140 (Compiled by Bengaluru Newsroom)

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Wall Street analyst revisions on U.S. companies

Related News

Arena Group plans name change to Paradium.AI, ticker to PAAI by Aug. 31, 2026

Iran vows 'devastating' response to US threat to cut off its economic lifelines

OSI Systems, Inc. <OSIS.O>: B. Riley cuts target price to $265 from $320

U.S. Stocks on the Move-Gold miners, Ross Stores, Stoke Therapeutics

Prudential CFO Frias joins Barclays Global Financial Services Conference fireside chat